← Leaderboards
Raphael Lis
Weill Medical Coll Of Cornell Univ
$1,956,267
Attributed
$6,625,809
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,625,809 · 4
By mechanism
R61$3,589,575 · 2
R33$3,036,234 · 2
Top collaborators
- Dritan Agalliu6 shared
- Irene Munk Pedersen6 shared
- Linnie Golightly5 shared
- Ben Adu Gyan5 shared
- David Charles Lyden5 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Olivier Elemento$10,592,678
- David S. Rickman$6,692,454
- Benjamin A Garcia$15,111,941
- Costantino Iadecola$45,312,269
- Steven Zvi Josefowicz$9,023,527
Others in their field
Other Emerging Leaders on “Transcriptomics”
- Evan Z Macosko · Broad Institute, Inc.$38,970,817
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$30,173,550
- Kathleen Maletic Neuzil · Emory University$26,258,144
- Hemali Phatnani · New York University School Of Medicine$24,538,801
- Patricia Shifflett · Westat, Inc.$16,650,520
Research focus
TranscriptomicsProteinsTranscription FactorPericytesPharmaceutical PreparationsPlasmaInnovationProtocols DocumentationMolecularPathogenesisPeripheralBloodBlood - Brain Barrier AnatomyPhysiologicalInduced Pluripotent Stem CellInflammatoryCellsBlood VesselsBrainBrain Endothelial CellBrain InjuriesOrganoidsFunctional DisorderCell Line
Grant awards (11)
Assessing the effects of peripheral immune activation on the NVU following TBI using a vascularized and perfused human blood/BBB model$577,505
R33 · FY2025 · HL
In vitro modeling of blood brain barrier dysfunction on a chip to elucidate the pathogenesis of cerebral malaria$463,994
R33 · FY2025 · HL
Assessing the effects of peripheral immune activation on the NVU following TBI using a vascularized and perfused human blood/BBB model$540,496
R33 · FY2024 · HL
In vitro modeling of blood brain barrier dysfunction on a chip to elucidate the pathogenesis of cerebral malaria$429,639
R33 · FY2024 · HL
Assessing the effects of peripheral immune activation on the NVU following TBI using a vascularized and perfused human blood/BBB model$565,433
R33 · FY2023 · HL
In vitro modeling of blood brain barrier dysfunction on a chip to elucidate the pathogenesis of cerebral malaria$459,167
R33 · FY2023 · HL
Assessing the effects of peripheral immune activation on the NVU following TBI using a vascularized and perfused human blood/BBB model$944,440
R61 · FY2022 · HL
In vitro modeling of blood brain barrier dysfunction on a chip to elucidate the pathogenesis of cerebral malaria$827,608
R61 · FY2022 · HL
Assessing the effects of peripheral immune activation on the NVU following TBI using avascularized and perfused human blood/BBB model.$17,898
R61 · FY2022 · HL
Assessing the effects of peripheral immune activation on the NVU following TBI using a vascularized and perfused human blood/BBB model$952,000
R61 · FY2021 · HL
In vitro modeling of blood brain barrier dysfunction on a chip to elucidate the pathogenesis of cerebral malaria$847,629
R61 · FY2021 · HL